---
title: "Bioxcel Therap (BTAI.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BTAI.US/norm.md"
symbol: "BTAI.US"
name: "Bioxcel Therap"
parent: "https://longbridge.com/en/quote/BTAI.US.md"
datetime: "2026-05-20T15:57:35.969Z"
locales:
  - [en](https://longbridge.com/en/quote/BTAI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BTAI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BTAI.US/norm.md)
---

# Bioxcel Therap (BTAI.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5400 | -0.5740 | -2.18 | -2.45 | -1.50 |
| ROE | 50.51% | 54.43% | 125.79% | 77.59% | 31.66% |
| Revenue | 206000.00 | 256000.00 | 98000.00 | 120000.00 | 168000.00 |
| Net income | -12.69M | -12.54M | -30.91M | -19.19M | -7.25M |
| Operating income | -10.22M | -10.28M | -14.03M | -15.85M | -10.10M |
| Gross margin | -37.38% | 87.50% | 88.78% | 10.83% | 91.67% |
| Net margin | -6160.68% | -4900.39% | -31541.84% | -15989.17% | -4317.86% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 34.02M | 44.92M | 44.79M | 25.79M | 38.57M |
| Leverage | -0.3224 | -0.4705 | -0.5037 | -0.2395 | -0.4277 |
| BVPS | -3.90 | -4.28 | -4.45 | -16.26 | -16.49 |
| Turnover | 0.0187 | 0.0154 | 0.0161 | 0.0190 | 0.0306 |
| Cash & STI | 17.18M | 28.41M | 36.18M | 17.43M | 31.01M |
| Inv & Rec | 500000.00 | 722000.00 | 459000.00 | 506000.00 | 642000.00 |
| LT assets | 117000.00 | 231000.00 | 389000.00 | 546000.00 | 702000.00 |
| Net debt | 83.11M | 81.24M | 73.11M | 91.51M | 74.86M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -11.81M | -14.21M | -18.79M | -12.57M | -12.04M |
| Investing CF | - | - | - | - | - |
| Financing CF | 232000.00 | 5.65M | 37.53M | 137000.00 | 13.20M |
| Free CF | -3.16M | -5.84M | -9.62M | -7.00M | -7.55M |
| OCF coverage | -145.65% | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |